Platform
Features
0 followers
Follow
Longevity Biotech is developing a new class of therapeutic candidates called Hybridtides. Their focus is on delivering clinically transformative products that tackle the most challenging aspects of medicine today.
Industries
Headquarters
Employees
Links
Scott Shandler
3 members
Genentech
150 followers
Illumina
67 followers
Agilent Technologies
63 followers
Cytiva
10 followers
Avantor
Promega
8 followers
United Therapeutics
7 followers
Calico
6 followers
Sage Therapeutics
5 followers
Repligen
4 followers
Merck
215 followers
Explore companies